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Depression and different anxiety disorders belong to the most common public health 
problems in the world today. At least 25 % of all woman and 15 % of all men will at least 
once during their lifetime seek treatment for a depressive episode. The treatment 
alternatives are many and vary depending on the severity and precipitating 
circumstances; everything from consolidating interview, psychotherapy, anti-depressive 
medicines to electro-convulsive therapy. Several of them are very effective, however, not 
all patients respond to antidepressants and there may be considerable side effects.  
 
A relatively recent form of treatment is chronobiology, where the organic circadian 
rhythm is pre-dominantly manipulated to treat mental symptoms. Previous studies have 
shown results suggesting that bright light therapy could be an adjuvant treatment to other 
antidepressants, not only in seasonal affective disorder but also in major depression. The 
Swedish National Board of Health and Welfare (Socialstyrelsen), however, has called for 
more evidence from scientific research before recommending light therapy. 
!
Aim 
The aim of this thesis was to evaluate the role of the most common chronobiological 
method, bright light therapy, as adjuvant treatment in patients with affective disorder and 
contribute to the knowledge of light therapy and its possible impact on depression, 
insomnia and medication needed.   
!
Methods 
Bright light therapy was introduced as an adjuvant therapy and offered to suitable 
patients admitted to Department 363 Sahlgrenska University Hospital/Östra in October 
2013. Patient records were collected prospectively for those receiving bright light therapy 
as adjunctive treatment and retrospectively for historical controls. The first 18 
consecutive patients who completed the adjuvant bright light therapy were included. For 
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each of the 18 patients two patients admitted up to three years previously were included 
as controls. The controls had to: a) be same sex, b) be at a similar age at admission 
(within one to two years) and c) meet the criteria for bright light therapy without it being 
available.  
 
The patient records included results from the two questionnaires: The Insomnia Severity 
Index (ISI) and the self-rating version of Montgomery–Åsberg Depression Rating Scale 
(MADRS-S). ISI is a diagnostic questionnaire used to evaluate the severity of insomnia 
and MADRS-S is a diagnostic questionnaire used to evaluate the severity of depressive 
disorders in affective patients.  
 
Results  
The mean age in the bright light therapy group was 39.1 years compared to 38.8 in the 
control group and in each group there were more woman, 72 %. The mean length of stay 
was 16 days for the light therapy group and 19 for the control group - a 3-day shorter stay 
for the those who had received bright light therapy. The mean MADRSs end score was 
27 points for the light therapy group and 23 for the control group - a 4-point higher score 
for the patients who had received light therapy. The total accumulated dose of diazepam 
equivalent of benzodiazepine for the whole hospital stay for the control group was 100 
mg and 75 for the light therapy group. Patients did not experience severe side effects and 
no patient switched to a manic state. The daily average dosage was 4.8 respectively 4.3 
mg/day. However, these results did not reach statistical significance. 
!
Discussion and conclusion 
This study did not find a significantly more rapid improvement in depressive self-scoring 
and insomnia which might be due to too small groups. Though, it provides support to 
continue studying light therapy in patients with affective disorder as the results point in 
the direction that light therapy possibly could shorten the length of stay and reduce the 
consumption of diazepam Also there were few to no side effects and light therapy could 
be a valuable alternative for hard-to-treat patients. A randomized controlled trial with a 
higher number of patients would be necessary for achieving high statistical power. It 
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would also be interesting if such a study looked further into the use of benzodiazepines 
and if it would be possible to decrease the use of these highly dependence producing 
medications with light therapy.   
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Introduction!!
Depression and insomnia 
According to the Swedish National Board of Health and Welfare (Socialstyrelsen - a 
Swedish government agency) depression and different anxiety disorders belong to the 
most common public health problems in the world today. In Sweden at least 25 % of all 
woman and 15 % of all men will at least once during their lifetime seek treatment for a 
depressive episode. These numbers differ from different studies and depending on how 
you classify different affective disorders [1].  
 
Sleep problems are a common symptom of various psychiatric disorders and particularly 
in depression. A majority of depressed patients (about two thirds) suffer from insomnia or 
other sleep problems [2]. Sleep problems increase the risk of developing suicidal 
tendencies and poorer treatment outcome and should accordingly be counted as a core 
symptom of depression [3], [4].  
Biological rhythms in psychiatry 
Observations have been made showing that some affective disorders show periodicity 
associated with various factors, such as winter depression with the seasons, and also for 
patient with rapid cycling bipolar disorder [5]. During a depression the diurnal cycle of 
cortisol gets arrhythmic and the cortisol levels get higher, reflecting an internal 
desychronization [6]. There is well-documented research on circadian fluctuation in 
depressed patients' mood and behavior, which can be related to neuroendocrine and 
physiological changes in the brain [7]. This may be seen as evidence that depression 
reflects an internal desynchronization of endogenous chemicals and hormones in the 
brain [8].  
Biological!mechanism!of!circadian!timing!
The main control of the circadian system in the brain and body is the so-called biological 
clock, located in the hypothalamus (the SCN, the suprachiasmatic nucleus) that drives the 
circadian rhythms and makes our biological day slightly longer than 24 hours [9]. The 
SCN is synchronized to the light cycle via retinal input. Light has decisive effect in 
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human circadian rhythm and this effect appears to be stronger than the social effects. 
Studies show that even though light is not the only input that controls the circadian 
rhythms, it is probably the most powerful input, more powerful than social input [10] or 
even darkness and sleep [11]. 
 
Controlled by the SCN, the hormone melatonin is produced in the corpus pineale. Retinal 
light inhibits the synthesis of melatonin. Meanwhile, melatonin has a blocking effect on 
melatonin receptors in the SCN [12]. If administrated as a pill, melatonin can be given to 
induce sleep and synchronize the circadian rhythm [13]. The timing of light or melatonin 
intake is important in the regulation of the circadian rhythm and biological clock. 
Morning light or evening administrated melatonin shifts the biological clock earlier, and, 
whereas evening light or morning administrated melatonin shift the biological clock later 
[14], [15], [16].  
 
Non-light-dependent neurochemical input to the SCN comes from the nucleus raphe 
(serotonergic enervation). Social factors, such as working schedules and daily routines, 
activates directly or indirectly the SCN, since they determine the timing of food intake, 
bedtime, physical labor and so on [17]. The SCN also gets input from the parts of the 
brain that controls sleep regulation. In addition to the brain's primary biological clock, we 
have circadian oscillators in all the body’s organs and cells, so-called peripheral clocks 
[18]. The homeostatic sleep pressure interacts with the circadian pacemaker depending on 
the timing and structure of sleep. According to this model, deregulation of both processes 
lead to depression and their interaction may explain mood fluctuations during the day 
[19].  
Treatment alternatives 
The treatment alternatives are many when it comes to depression. Several of them are 
very effective, but not all patients respond to antidepressants or tolerate all the medicines. 
Also there is the problem with the slow onset of action, which makes it necessary for 
some patients to stay a long time at hospital in order to be monitored until the 
antidepressants show effect. Electroconvulsive treatment is fast but has several 
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disadvantages, such as necessary anesthesia and side effects. This indicates that more 
options with fast onset and few side effects that could be combined to different treatments 
are needed. Studies show that light therapy is effective in different types of depression 
and is a good alternative as an adjuvant to the normal treatment [20]. 
 
Most antidepressant medications affect sleep pattern. Some antidepressants may have an 
activating effect; others may have sedative effects by affecting either histamine receptors 
or sigma receptors [21]. Several studies show that combined antidepressant and hypnotic 
medication lead to better results and faster improvements [22]. Melatonin agonists (such 
as agomelatine) seem to have both antidepressant and sedative effect by advancing the 
circadian phase [23]. 
 
Normally, hypnotics are prescribed to patients with insomnia regardless of underlying 
diagnosis. There are several medications without documented addictive effects 
(alimemazin, prometiazin, hydroxizin), but there is not clear evidence that they affect 
sleep patterns negatively.  However, they do have long half-life and can cause unpleasant 
side effect such as daytime sleepiness. Benzodiazepine hypnotics and hypnotics with 
similar pharmacological profiles have a more selective sleep effect, but their long-term 
effect is more questionable. This type of medication affects the sleep pattern from long-
term use, although the tolerant-generating effects are overestimated [24].  
What is chronobiological therapy? 
Bright light therapy arises from chronobiological therapy which is defined as the 
“controlled exposure to environmental stimuli that act on the biological rhythms” to 
achieve therapeutic efficacy of certain psychiatric disorders [25], [26].  
Light therapy 
The psychiatrist and scientist Norman E. Rosenthal was the first to describe seasonal 
affective disorder and as treatment tried to mimic a summer day through light therapy in 
the early 1980s [27]. Ever since 1984 when Rosenthal reported on the first clinical trial of 
light therapy this field of science has developed tremendously [28]. It has now been 
shown in repeated studies that it is not necessary to mimic a whole summer day, 30 
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minutes is sufficient [29], [30]. There is reasonable evidence that light therapy is 
significantly more effective than placebo in patients with depression [31]. A double 
blinded, placebo controlled study where light therapy was used as an adjuvant to SSRI 
treatment showed more rapid (within a week) and more profound (more than 30 %) 
improvements in the light therapy group compared to the control group [32], [33]. Light 
therapy according to current protocol is a safe method with few side effects [34] that can 
synchronize circadian rhythms and also has energizing effect even in healthy individuals 
[35].  
 
Why more research on light therapy? 
Even though several studies indicate that light therapy has a positive effect on patients 
with depression the Swedish National Board of Health and Welfare (Socialstyrelsen) do 
not recommend light therapy with this indication. Socialstyrelsen has reviewed several 
articles on light therapy. However, all these do not follow the same protocols with a light 
box with a 10.000 lux capacity which the studies indicating that light therapy has good 
effect are based on. Also, Socialstyrelsen’s national guidelines on the subject were 
summarized in 2009 and are not completely up to date. In these guidelines they do not 
consider these studies sufficient to draw the conclusion that light therapy is a good 
compliment to medical treatment. However, they do recommend that light therapy should 




The aim was to evaluate bright light therapy as treatment adjuvant in admitted psychiatric 
patients with affective disorder. Specific outcomes studied were: self-rated depressive 
symptoms, self-rated insomnia and medication needed.  
 
The hypothesis was that light therapy could lead to faster response in depression, shorten 
length of hospital stay and improve sleep in patients with affective disorder.  The 
question I wanted to answer was twofold: Can light therapy lead to faster response in 
depression in affective patients and improve their sleep? And: Does light therapy as 




Bright light therapy was introduced as an adjuvant therapy offered to suitable patients 
admitted to Department 363 Sahlgrenska University Hospital/Östra in October 2013. 
Patient records were collected prospectively for the first 20 consecutive patients that had 
been treated with light therapy. Of these, 18 patients completed the light therapy 
treatment and were included in the light therapy group. One patient did not consider that 
she was in need of psychiatric care and wanted to go back to school and left the 
department prematurely. The second patient did not complete her light treatment because 
she did not enjoy the circumstances of the light treatment (having to get up early in the 
morning) but stayed at the hospital and continued her psychiatric medical treatment.   
 
To achieve a control group a list of all patients admitted to Department 363 from 1 
January 2010 to 30 September 2013 was requested with patients diagnosed with any of 
the following ICD-10 was used: 
F31.3 – Bipolar affective disorder, current episode mild or moderate depression 
F31.4 – Bipolar affective disorder, current episode severe depression without 
psychotic symptoms 
F31.8 – Other bipolar affective disorders 
F31.9 – Bipolar affective disorder, unspecified 
F32.0 – Mild depressive episode 
F32.1 – Moderate depressive episode 
F32.2 – Severe depressive episode without psychotic symptoms 
F32.8 – Other depressive episodes 
F32.9 – Depressive episode, unspecified 
F33.0 – Recurrent depressive disorder, current episode mild 
F33.1 – Recurrent depressive disorder, current episode moderate 
F33.2 – Recurrent depressive disorder, current episode severe without psychotic 
symptoms 
F33.4 – Recurrent depressive disorder, currently in remission  
F33.8 – Other recurrent depressive disorders 
F33.9 – Recurrent depressive disorder, unspecified 
 
For each of the 18 patients who recieved ligh therapy, two patients were included as 
controls who had to: a) be same sex b) be at a similar age at admission (within one to two 
years) and c) meet the criteria for bright light therapy without it being available.  
 12 
This resulted in a control group of 36 patients. In total 95 patients were examined from 
the list of possible patients for the control group, and 59 patients were not considered 
suitable for light therapy since they did not meet the criteria below or chose to 
discontinue their treatment prematurely.  
 
Even though the different data variables were supposed to be registered in the patient 
records according to the department routine this was not the always the case. Because of 
this all data for all variables could not be retrieved. The numbers of patients with 
available data are given in all tables. 
Criteria for light therapy 
The patient had to suffer from an affective disorder, including both unipolar and bipolar 
affective disorder, and insomnia. This affective episode could not be manic, hypomanic 
or rapid cycling. The patient had to be able to make his/her own informed decision 
whether to receive light therapy. The patient had to be over 18 but not be 70 years or 
older since these patients were supposed to be cared for in the psychiatric care for the 
elderly. The patient could not suffer from an ongoing psychosis and could not be treated 
for substance abuse or have withdrawal symptoms. The patient could not be acutely 
suicidal or treated under involuntary commitment (with support of Lagen om psykiatrisk 
tvångsvård, the Swedish Compulsory mental care act). The patient cannot undergo 
electroconvulsive therapy and receive light therapy.   
 
Other exclusion criteria were: epilepsy, age-related macular degeneration, retinal changes 
or other fundus diseases, porphyria, systemic lupus erythematosus, chronic actinic 
keratosis or solar urticaria, The patient could not use medication that can cause 
photosensitivity of the skin and eyes such as certain antipsychotics, psoralen, anti-
arrhythmic (amiodarone), antimalarial drugs, medicine for rheumatism, porphyrin or St. 




Philips EnergyLight HF3319/01 was selected as light source for the bright light therapy. 
Since there are no official agency regulating light boxes for light therapy, the light box 
was chosen in accordance with the clinical manual for light therapy Chronotherapeutics 
for affect disorders [36] that suggests that the lamp model should have been successfully 
used in peer-reviewed clinical trials, have sufficient ultraviolet screening and provide soft 
broad-band white light up to 10.000 lux of illumination at a comfortable distance for the 
patient. The Philips EnergyLight HF3319/01 meet these criteria and has meets the criteria 
for safety regarding UV screening according to the European Declaration of Conformity.  
Treatment 
Since it is not practical to measure melatonin in blood an estimation of the melatonin 
levels can be made using the self-assessment questionnaire Morningness-Eveningness 
Questionnaire (MEQ), which has shown good correlations between melatonin levels and 
different chronotypes in individuals [37]. To determine which time to start light therapy 
was most suitable the MEQ questionnaire was used. Since this questionnaire is not yet 
translated into Swedish, an English version was handed out to each patient to receive 
light therapy and, if needed, translated by the nursing staff to the patient. The treatment 
was given for 30 minutes each morning, at a predetermined time, at a sitting distance of 
15-20 centimeters. The patient was allowed to read a book, use his/her smart phone, eat 
breakfast or do other activities as long as the patient did not cover his/her eyes. The 
patient was also allowed to take smaller breaks to use the bathroom as long as the 
treatment continued within a few minutes.  
Data 
All clinical records from January 2010 were predefined to contain demographics. The 
demographics always registered were age, gender, employment status, home-ownership 
and relationship status.   
 
In the same way the patient records included results from the two questionnaires: the 
Insomnia Severity Index (ISI) and the self-rating version of Montgomery–Åsberg 
Depression Rating Scale (MADRS-S). ISI is a diagnostic questionnaire used to evaluate 
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the severity of insomnia. The score ranges from 0-28, where 28 is the most severe (see 
appendix). MADRS-S is a diagnostic questionnaire used to evaluate the severity of 
depressive disorders in affective patients. The score ranges from 0-60, where 60 is the 
most severe (see appendix). Both questionnaires are used as a routine in the department 
to monitor insomnia and depression from the day the patient is admitted to the psychiatric 
ward, and then weekly till the day the patient is discharge from the hospital. At the time 
for discharge the nursing staff has been informed to hand out these questionnaires one 
last time. 
 
Furthermore, psychiatric and somatic medication for each day of the hospital stay was 
collected. The psychiatric medication has been divided into five groups, based on the 
purpose of the medication: antidepressants, antipsychotics, mood stabilizers, hypnotics 
and sedatives. To convert benzodiazepines to diazepam the memorandum for equivalent 
doses of benzodiazepines used in Västra Götaland, Sweden was used (see appendix). 
Data analysis and statistical methods 
All data has been depersonalized and collected into an excel sheet. All statistical analyses 
were made using IBM SPSS statistics 22.0.0. (SPSS Inc, Chicago, IL, USA). To 
determine if the different sets of data from the two groups are significantly different from 
each other, a t-test has been used for each analysis. User defined missing values are 
treated as missing. Statistics for each analysis are based on the cases with no missing or 
out-of-range data for any variable in the analysis. 
Ethics!
As this study is considered to be a quality control study, this study did not need to be 
approved by the Ethics committee according to the Swedish legislation.  
 
Since light therapy is a non-invasive, well defined and considered to be one of the safest 
treatments in psychiatric care, with negligible short-term side effect and no known long-
term side effects, that has been studied and implemented in treatment routines in hospitals 
all over the world [35], no special ethical considerations were required.  
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Results!
These are the results for the first consecutive 18 patients from 1 October 2013 who has 
fulfilled their light therapy treatment at Department 363 Sahlgrenska University 
Hospital/Östra and the control group of 36 patients with same sex and closest possible 
similar age fulfilling the criteria of light therapy, identified from a list of all patients from 
1 January 2010 to 30 September 2013, diagnosed with an affective disorder.   
Demographics 
Demographic variables of the light therapy group and the control group are displayed in 
table I. The mean age was 39.06 years for the light therapy group and 38.81 for the 
control group, and 72 % were females and 28 % males in both groups. Patients living 
with a partner was 28 % for the light therapy group and 22 % for the control group and 
all patients in the light therapy group (100 %) were currently living in their own home 
and were not living in a homeless shelter, institution, temporary housing or other facility 
compared to 78 % in the control group. The percentage of patients being employed, 
studying or receiving retirement pension due to age (not because of illness) was 39 % for 
the light therapy group and 58 % for the control group.  
 
Table I – Demographics of patients and controls 




Age 39.1±15.9 38.8±16.5 
  
Female gender 72 % 72 % 
  
Living with partner 28 % 22 % 
  
Employed or student 39 % 58 % 
  





The length of stay for the light therapy group and the control group are displayed in table 
II. The mean length of stay was 16.2 days for the light therapy group and 19.1 for the 
control group. This makes a difference of 2.9 days, or 15 % shorter hospital visit for the 
patients who had received the light therapy treatment. These results are not statistically 
significant.  
Table II – Main outcome of patients and control 




Hospital stay 16.2±7.0 19.11±8.2 
  
MADRS end score 27.5±13.7a 23.2±11.3b 
  
ISI end score 13.0±7.6a 13.2±7.3b 
  
a) n=17, b) n=28 
Montgomery-Åsberg Depression Rating Scale 
The MADRS-s end score for the light therapy group and the control group are displayed 
in table II. All of the 18 patients in the light therapy group, and 28 out of 36 in the control 
group self-rated themselves, before leaving the department. The mean MADRS-S end 
score was 27.5 points for the light therapy group and 23.2 for the control group. This 
makes a difference of 4.3 points, or 18 % higher score for the patients who had received 
the light therapy treatment.  
 
Table III shows the first and MADRS-S scores of the hospital stay. The mean 1st 
MADRS-S score was 32.22 for the light therapy group and 33.81 for the control group. 
This means that the light therapy group improved 4.75 points or 15 % during their stay, 
whereas the control group improved 10.6 points or 31 %. These results are not 






Table III – MADRS-s and ISI scores  




MADRS 1st score 32.2±13.0 33.8±9.7b 
  
MADRS end score 27.5±13.7a 23.2±11.3c 
  
ISI 1st score 16.4±6.3 19.2±6.6c 
  
ISI 1 end score 13.0±7.6a 13.2±7.3c 
  
a) n=17, b) n=31, c) n=28 
Insomnia Severity Index 
The ISI end score for the light therapy group and the control group are displayed in tables 
II and III. In total, 17 out of 18 patients in the light therapy group and 28 out of 36 in the 
control group self-rated themselves before leaving the department. The mean ISI end 
score was 13.00 points for the light therapy group and 13.18 for the control group. This 
makes a difference of 0.18 points, or 1 % lower score for the patients who had received 
the light therapy treatment. 
 
Table III shows the first and last ISI scores of the hospital stay. The mean 1st ISI score 
was 16.44 for the light therapy group and 19.21 for the control group, which means that 
the light therapy group improved 3.44 points or 21 % during their stay, whereas the 









The percentage of patients taking psychiatric medication in the light therapy group and 
the control group are displayed in table IV.  All of the 18 patients in the light therapy 
group and 35 out of 36 in the control group were medicated with a therapeutic dose of 
one or more antidepressants. None of the patients in the light therapy group were taking 
antipsychotics and 2 out of 36 in the control group were medicated with an antipsychotic 
(but not as primary treatment). Out of the 18 patients in the light therapy group 6 (33 %) 
were under treatment with mood stabilizers (5 of these with quetiapin) and in the control 
group 4 out of the 36 (11 %) were under treatment with mood stabilizers (2 with 
quetiapin). 89 % in the light therapy group were taking hypnotics, and 92 % in the control 




















This figure of Table III compares the Light therapy group’s and the 
Control group’s results and improvements of the self-scoring 
questionnaires MADRS-s (for depression) and ISI (for insomnia) 
during the hospital stay. 
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Table IV – Psychiatric medication during the 
hospital stay  




Antidepressants 100 % 97 % 
  
Antipsychotics 0 % 6 % 
  
Mood stabilizers 33 % 11 % 
  
Hypnotics 89 % 92 % 
  
Sedatives 89 % 89 % 
  
 
Table 5 shows that the control group consumed benzodiazepines converted to diazepam 
in greater quantities than the light therapy group. The accumulated dose for the whole 
hospital stay for the control group was 99.8 mg and 75.2 for the light therapy group, 75 % 
of the control group’s consumption. The light therapy group consumed 4.3 mg/day and 
the control group 4.8 mg/day, 11 % more than the light therapy group.  
 
Table V – Consumed benzodiazepines 
converted to diazepam during the hospital stay 




Mg/hospital stay 39.1±15.9 38.8±16.5 
  







This study indicates a possible faster improvement as the light therapy group stayed three 
days shorter than the control group. The mean length of stay was 16 days for the light 
therapy group and 19 for the control group. These results point towards the same 
conclusion in a double blinded study where more rapid improvement were found, but also 
more profound improvements of major depression (30 %) which this study does not show 
[38]. Howeve[r it is not possible to interpret these findings due to the low statistical 
power, and it is even harder do draw any conclusions when the MADRS-S scores are 
lower at start in the light therapy group compared to the control group but higher at the 
end of treatment. The mean MADRS-S end score was 27 points for the light therapy 
group and 23 for the control group. This is somewhat contradictory.  
 
One possible reason may be the fact that 94 % of the patients in the light therapy group 
answered the end questionnaire, but only 78 % of the control group, and those who did 
not want to rate themselves were dissatisfied with their stay and would have given a 
higher score. The attending physician has in any case assessed the patients as ready for 
discharge, which would indicate that they felt well enough and had improved in their 
depression. 
 
It is interesting how the patients in the light therapy group 5 times as often were given 
quetiapin compared with the control group. This could be explained by new treatment 
routines. Quetiapin has become more popular to give in a mood stabilizing purpose, and 
the control group was identified from data reaching from 2010 to 2013, and light therapy 
started 1 October 2013. It is also interesting that light therapy may reduce the use of 
benzodiazepines. The total accumulated dose of diazepam equivalent of benzodiazepine 
for the whole hospital stay for the control group was 100 mg and 75 for the light therapy 
group. The daily average dosage was 4.8 respectively 4.3 mg/day. These results may be 
secondary to higher use of quetiapin and there is difficult to make any conclusions with 
the low statistical power. 
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However, discrepancy between all demographic variables except age and gender are vast, 
especially whether the patient is owner of his/her own home or not. Since all patients who 
have received treatment with light therapy have had the choice to choose whether they 
want light therapy or not and the control group were chosen based on whether they could 
theoretically be offered therapy or not, this study includes patient in the control group 
who are suited for light therapy but would have said no to receive light therapy in real 
life. There may be variables that have not been considered or are hard to detect in the 
patients records, which could be crucial for whether a patient is suitable or not for light 
therapy.   
 
To make the light therapy group and the control group more homogeneous it would have 
been possible to only choose patients to the control group who had been admitted during 
the same time of the year as the patients who received light therapy and narrow down the 
ICD-codes and. For instance if only patients with moderate and severe depressive episode 
were allowed to be in the study. However, this would have reduced the numbers of 
patients in both the light therapy group and the control group even more, which would 
have led to even more difficulties to interpret the results and get any significant results.  
 
This study is limited both due to a small number of patients in both groups and due to the 
retrospectively collected data from the patient records resulting in missing data and 
possible inaccuracy in interpretation of data due to human error. In the future a 
randomized control study where patients are randomly allocated to either receive 
chronobiological treatment or some other kind of treatment (for example sleep hygiene) 
would solve this problem. It would even be possible to make the study blinded by for 
instance giving the control group dim light instead of bright light  [32], [33]. 
 
Other ways to improve the conditions of future chronobiological projects could be to look 
over the self-assessment questionnaires. One way would be to translate the Morningness-
Eveningness Questionnaire (MEQ) from English to Swedish for more correct results 
estimations of melatonin levels [37].  Even though no patient in this study seemed to be 
bothered by this questionnaire being in English and that the nursing staff could help to 
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translate questions if needed, a Swedish version of MEQ would be helpful future patients. 
Also an additional questionnaire to rate depression could be The Hamilton Rating Scale 
for Depression (HAM-D) for better possibilities to compare results with from other 
studies on light therapy  [32], [33]. 
 
It would also be interesting not only to measure results from self-rating scales but also to 
measure the serum levels of the hormones melatonin and cortisol and possible changes of 
these before, during and after treatment, since these hormones diurnal rhythmic 
fluctuations and serum levels often change during a depressive episode [6], [7]. This 
would give an objective evaluation of how light therapy affect the circadian rhythm in 
patients with depression. However, this would increase the costs of the project vastly as 
several measurements of the serum levels each day would be necessary. This would also 
be an invasive and possibly a bothersome moment for the patients. 
Conclusion!
This study could not present a statistically significant more rapid improvement in 
depressive self-scoring and insomnia.  Though, it provides support to continue studying 
light therapy in patients with affective disorder, just like Socialstyrelsen recommends [1]. 
A randomized control trial with a higher number of patients would have better 
qualifications to get results with high statistical power. It would also be interesting if such 
a study looked into the use of diazepam, and if it would be possible to decrease the use of 






Det finns starka samband mellan sömn och depression. Sömnbesvär ses som ett av 
kärnsymptomen hos deprimerade patienter. För lite ljus kan ge negativa effekter på 
hjärnan och depression kan spegla en rubbning av hormoner och signalsubstanser som 
styr sömn-vakenhetscykeln. 
 
Det finns forskning som visar att ljusterapi tillsammans med läkemedelsbehandling har 
positiv effekt på depression. Teorin är att genom ljusterapi som simulerar dagsljuset kan 
kroppens produktion av hormonet melatonin styras för att få dygnsrytmen i fas, förbättra 
sömn och lindra depressiva besvär. Socialstyrelsen önskar ytterligare forskning på 
området med ljusbehandling innan de vill rekommendera svenska sjukhus att använda 
ljusbehandling för deprimerade patienter.  
 
Ljusbehandling går till så att patienten på morgonen sitter bekvämt framför ljuslampan på 
15-20 cm avstånd under 30 minuter. Ljuslampan filtrerar bort UV-ljus och lyser med en 
effekt på 10,000 lux. Detta kan jämföras med solens belysning med 100,000 lux en solig 
sommardag och 250-500 lux inomhus med normal takbelysning.  
 
I studien jämfördes patienter som fått ljusbehandling och patienter som inte har fått det 
gällande psykisk hälsa, sömn, medicinering samt vårdtid. Detta har varit möjligt eftersom 
det finns resultat från skattningsformulär för sömnbesvär och depressiva besvär för alla 
patienter sedan flera år tillbaka på avdelningen i patientjournaler.  
 
Vi tittade på de första 20 patienterna som genomgått ljusbehandling men två avbröt 
behandlingen och jämförde de 18 kvarstående med 36 patienter som uppfyllde alla krav 
för ljusbehandling, men som vårdades innan behandlingsmetoden infördes som rutin på 
avdelningen.  
 
Studien kunde dock inte med statistisk säkerhet visa att ljusbehandling skulle leda till 
kortare vårdtid, snabbare och större förbättring av depressiva besvär och sömnbesvär eller 
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minska intaget av lugnande medicin. Det vill säga, man kan inte utesluta att slumpen är 
mer avgörande än ljusbehandlingen för resultaten. Vissa av resultaten pekar dock på att 
ljusbehandling möjligtvis kan leda till snabbare förbättring och mindre användning av 
vissa lugnande läkemedel, men å andra sidan pekar andra resultat på att de som inte fått 
ljusbehandling förbättrades mer och mådde bättre vid utskrivning än de som hade fått 
ljusbehandling.  
 
Det vore intressant att fortsatt i framtiden göra en kontrollerad studie med fler patienter 
där man lottar patienterna om de ska få ljusbehandling eller inte.  Då kan man få säkrare 
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Det är helt frivilligt att besvara frågorna i formuläret. Genom 
att besvara dem ger du ditt samtycke till att din behandlare får 
ta del av resultatet. Avsikten med frågorna är att få en detalje-
rad bild av hur du mår psykiskt. Du och din behandlare kom-











Här ber vi dig beskriva din sinnesstämning, om du känner dig 
ledsen, tungsint eller dyster till mods. Tänk efter hur du har 
känt dig de senaste tre dagarna, om du har skiftat i humöret  
eller om det har varit i stort sett detsamma hela tiden, och  
försök särskilt komma ihåg om du har känt dig lättare till  
sinnes om det har hänt något positivt.  
 
0 Jag kan känna mig glad eller ledsen, allt efter 
 omständigheterna. 
1 
2 Jag känner mig nedstämd för det mesta, 
 men ibland kan det kännas lättare. 
3 
4 Jag känner mig genomgående nedstämd och dyster. 
 Jag kan inte glädja mig åt sådant som vanligen 
 skulle göra mig glad. 
5 
6 Jag är totalt nedstämd och olycklig att jag 





Här ber vi dig markera i vilken utsträckning du har haft känslor 
av inre spänning, olust och ångest eller odefinierad rädsla un-
der de senaste tre dagarna. Tänk särskilt på hur intensiva käns-
lorna varit, och om de kommit och gått eller funnits hela tiden. 
 
0 Jag känner mig mestadels lugn. 
1   
2 Ibland har jag obehagliga känslor av inre oro. 
3   
4 Jag har ofta en känsla av inre oro som ibland kan bli 
mycket stor, och som jag måste anstränga mig för att 
bemästra. 
5   














Frågorna innehåller en rad olika påståenden om hur man kan 
må i olika avseenden. Påståendena uttrycker på en skala 0-6 
olika grader av psykiska besvär, alltifrån frånvaro av besvär  
(0 poäng) till maximalt uttalade besvär (6 poäng). Sätt en ring 
runt siffran som du tycker bäst stämmer överens med hur du 
mått de senaste tre dagarna. Tänk inte allt för länge, utan  






Här ber vi dig beskriva hur bra du sover. Tänk efter hur länge 
du sovit och hur god sömnen varit under de senaste tre nätter-
na. Bedömningen skall avse hur du faktiskt sovit, oavsett om 
du tagit sömnmedel eller ej. Om du sover mer än vanligt, sätt 
din markering vid 0. 
 
0 Jag sover lugnt och bra och tillräckligt länge för mina  
behov. Jag har inga särskilda svårigheter att somna. 
1 
2 Jag har vissa sömnsvårigheter. Ibland har jag svårt 
att somna eller sover ytligare eller oroligare än vanligt. 
3 
4 Jag sover minst två timmar mindre per natt än normalt. 
Jag vaknar ofta under natten, även om jag inte blir störd. 
5 





Här ber vi dig ta ställning till hur din aptit är, och tänka efter 
om den på något sätt skilt sig från vad som är normalt för dig. 
Om du skulle ha bättre aptit än normalt, markera då det på 0. 
 
0 Min aptit är som den brukar vara. 
1 
2 Min aptit är sämre än vanligt. 
3 
4 Min aptit har nästan helt försvunnit. 
5 
6 Jag vill inte ha någon mat. Om jag skall få någonting i 
mig, måste jag övertalas att äta. 
 
 
  Namn  Personnummer  Datum 
KOM IHÅG, att bedömningen endast gäller de senaste tre dagarna.
1. Sinnesstämning 3. Sömn
2. Oroskänslor 4. Matlust
 Summa denna sida: 
, att bedömningen endast gäller de senaste tre dagarna.KOM IHÅG
 
 
Här ber vi dig ta ställning till din förmåga att hålla tankarna 
samlade och koncentrera dig på olika aktiviteter. Tänk igenom 
hur du fungerar vid olika sysslor som kräver olika grad av 
koncentrationsförmåga, t ex läsning av komplicerad text, lätt 
tidningstext och TV-tittande. 
 
0 Jag har inga koncentrationssvårigheter. 
1 
2 Jag har tillfälligt svårt att hålla tankarna samlade på 
 sådant som normalt skulle fånga min uppmärksamhet 
 (t ex läsning eller TV-tittande). 
3 
4 Jag har påtagligt svårt att koncentrera mig på sådant 
 som normalt inte kräver någon ansträngning från min 
 sida (t ex läsning eller samtal med andra människor). 
5 






Här ber vi dig försöka värdera din handlingskraft. Frågan gäller 
om du har lätt eller svårt för att komma igång med sådant du 
tycker du bör göra, och i vilken utsträckning du måste  
övervinna ett inre motstånd när du skall ta itu med något. 
 
0 Jag har inga svårigheter med att ta itu med nya uppgifter. 
1 
2 När jag skall ta itu med något, tar det emot på 
 ett sätt som inte är normalt för mig. 
3 
4 Det krävs en stor ansträngning för mig att ens komma 
igång med enkla uppgifter som jag vanligtvis utför mer  
eller mindre rutinmässigt. 
5 






Här ber vi dig ta ställning till hur du upplever ditt intresse för 
omvärlden och för andra människor, och för sådana aktiviteter 
som brukar bereda dig nöje och glädje. 
 
0 Jag är intresserad av omvärlden och engagerar mig i den, 
och det bereder mig både nöje och glädje. 
1 
2 Jag känner mindre starkt för sådant som brukar engagera 
mig. Jag har svårare än vanligt att bli glad eller svårare att 
bli arg när det är befogat. 
3 
4 Jag kan inte känna något intresse för omvärlden, 
inte ens för vänner och bekanta. 
5 
6 Jag har slutat uppleva några känslor. Jag känner mig 






Frågan gäller hur du ser på din egen framtid och hur du uppfat-
tar ditt eget värde. Tänk efter i vilken utsträckning du ger dig 
självförebråelser, om du plågas av skuldkänslor, och om du 
oroat dig oftare än vanligt för t ex din ekonomi eller din hälsa. 
5. Koncentrationsförmåga 6. Pessimism
 
0 Jag ser på framtiden med tillförsikt. Jag är på det hela  
taget ganska nöjd med mig själv. 
1 
2 Ibland klandrar jag mig själv och tycker att jag är mindre 
värd än andra. 
3 
4 Jag grubblar ofta över mina misslyckanden och känner 
mig mindervärdig eller dålig, även om andra tycker  
annorlunda. 
5 
6 Jag ser allting i svart och kan inte se någon ljusning. Det 
känns som om jag var en alltigenom dålig människa, och 
som om jag aldrig skulle kunna få någon förlåtelse för det 




Frågan gäller din livslust, och om du känt livsleda. Har du  
tankar på självmord, och i så fall, i vilken utsträckning  
upplever du detta som en verklig utväg? 
6. Initiativförmåga 9. Livslust
 
0 Jag har normal aptit på livet. 
1 
2 Livet känns inte särskilt meningsfullt men jag önskar ändå 
inte att jag vore död. 
3 
4 Jag tycker ofta det vore bättre att vara död, och trots att jag 
egentligen inte önskar det, kan självmord ibland kännas 
som en möjlig utväg. 
5 
6 Jag är egentligen övertygad om att min enda utväg är att 
dö, och jag tänker mycket på hur jag bäst skall gå tillväga 






7. Känslomässigt engagemang NEDANSTÅENDE FYLLS I AV VÅRDPERSONAL
 
 
 Summa denna sida:  
 
 
















Insomnia Severity Index (ISI) 
 
Bedöm hur pass allvarliga dina sömnsvårigheter har varit de senaste två veckorna. 
 
 
Svårigheter Inga Små Medel Stora Mycket 
stora 
1. Somna på kvällen 0 1 2 3 4 
 
2. Vakna upp under natten 0 1 2 3 4 
 




4. Hur missnöjd är du med ditt nuvarande sömnmönster? 
     
Mycket nöjd Nöjd Varken eller Missnöjd Mycket missnöjd 
 




5. I hur pass hög grad anser du att dina sömnsvårigheter stör dig i din vardag (t.ex. trötthet, 
arbete, fritid, koncentration, minne och humör)? 
 
Inte alls störande Lite störande Något störande Klart störande Mycket störande 
 










Lite märkbart Något märkbart Klart märkbart Mycket märkbart 




7. Hur oroad är du över dina nuvarande sömnsvårigheter? 
 
Inte alls oroad Lite oroad Något oroad Klart oroad Mycket oroad 
 
0 1 2 3 4 
 
     
 
 
ISI = Insomnia Severity Index (Morin. 1993).  
  
MORNINGNESS-EVENINGNESS QUESTIONNAIRE (MEQ) 
 
Instructions: 
x Please read each question very carefully before answering. 
x Please answer each question as honestly as possible.  
x Answer ALL questions. 
x Each question should be answered independently of others. Do NOT go back and check your answers. 
 
1.  What time would you get up if you were entirely free to plan your day? 
 
 
5:00 – 6:30 AM 5 
6:30 – 7:45 AM 4 
7:45 – 9:45 AM 3 
9:45 – 11:00 AM 2 
11:00 AM – 12 NOON 1 
12 NOON – 5:00 AM 0 
 
 
2.  What time would you go to bed if you were entirely free to plan your evening? 
 
8:00 – 9:00 PM 5 
9:00 – 10:15 PM 4 
10:15 PM – 12:30 AM 3 
12:30 – 1:45 AM 2 
1:45 – 3:00 AM 1 
3:00 AM – 8:00 PM 0 
 
 
3.  If there is a specific time at which you have to get up in the morning, to what extent do you 
depend on being woken up by an alarm clock? 
 
Not at all dependent 4 
Slightly dependent 3 
Fairly dependent 2 
Very dependent 1 
 
 
4.  How easy do you find it to get up in the morning (when you are not woken up unexpectedly)? 
 
Not at all easy 1 
Not very easy  2 
Fairly easy  3 
Very easy  4 
 
  
5.  How alert do you feel during the first half hour after you wake up in the morning? 
 
Not at all alert 1 
Slightly alert 2 
Fairly alert 3 
Very alert 4 
 
6.  How hungry do you feel during the first half-hour after you wake up in the morning? 
 
Not at all hungry  1 
Slightly hungry  2 
Fairly hungry  3 
Very hungry  4 
 
 
7.  During the first half-hour after you wake up in the morning, how tired do you feel? 
 
Very tired  1 
Fairly tired  2 
Fairly refreshed  3 
Very refreshed 4 
 
 
8.  If you have no commitments the next day, what time would you go to bed compared to your 
usual bedtime? 
 
Seldom or never later  4 
Less than one hour later  3 
1-2 hours later  2 
More than two hours later  1 
 
 
9.  You have decided to engage in some physical exercise. A friend suggests that you do this for one 
hour twice a week and the best time for him is between 7:00 – 8:00 am. Bearing in mind nothing 
but your own internal “clock”, how do you think you would perform? 
 
Would be in good form  4 
Would be in reasonable form  3 
Would find it difficult  2 
Would find it very difficult  1 
 
 
10. At what time of day do you feel you become tired as a result of need for sleep? 
 
8:00 – 9:00 PM 5 
9:00 – 10:15 PM 4 
10:15 PM – 12:45 AM 3 
12:45 – 2:00 AM 2 




11. You want to be at your peak performance for a test that you know is going to be mentally 
exhausting and will last for two hours. You are entirely free to plan your day. Considering only 
your own internal “clock”, which ONE of the four testing times would you choose? 
 
8:00 AM – 10:00 AM  4 
11:00 AM – 1:00 PM  3 
3:00 PM – 5:00 PM  2 
7:00 PM – 9:00 PM  1 
 
 
12. If you got into bed at 11:00 PM, how tired would you be? 
 
Not at all tired  1 
A little tired 2 
Fairly tired 3 
Very tired 4 
 
 
13. For some reason you have gone to bed several hours later than usual, but there is no need to get 
up at any particular time the next morning. Which ONE of the following are you most likely to 
do? 
 
Will wake up at usual time, but will NOT fall back asleep 4 
Will wake up at usual time and will doze thereafter 3 
Will wake up at usual time but will fall asleep again 2 
Will NOT wake up until later than usual 1 
  
 
14. One night you have to remain awake between 4:00 – 6:00 AM in order to carry out a night 
watch. You have no commitments the next day. Which ONE of the alternatives will suite you 
best? 
 
Would NOT go to bed until watch was over 1 
Would take a nap before and sleep after 2 
Would take a good sleep before and nap after 3 
Would sleep only before watch 4 
 
 
15. You have to do two hours of hard physical work. You are entirely free to plan your day and 








8:00 AM – 10:00 AM 4 
11:00 AM – 1:00 PM 3 
3:00 PM – 5:00 PM 2 
7:00 PM – 9:00 PM 1 
  
16. You have decided to engage in hard physical exercise. A friend suggests that you do this for one 
hour twice a week and the best time for him is between 10:00 – 11:00 PM. Bearing in mind 
nothing else but your own internal “clock” how well do you think you would perform? 
 
Would be in good form 1 
Would be in reasonable form 2 
Would find it difficult 3 
Would find it very difficult 4 
 
 
17. Suppose that you can choose your own work hours. Assume that you worked a FIVE hour day 
(including breaks) and that your job was interesting and paid by results). Which FIVE 
CONSECUTIVE HOURS would you select? 
 
5 hours starting between 4:00 AM and 8:00 AM 5 
5 hours starting between 8:00 AM and 9:00 AM 4 
5 hours starting between 9:00 AM and 2:00 PM 3 
5 hours starting between 2:00 PM and 5:00 PM 2 
5 hours starting between 5:00 PM and 4:00 AM 1 
 
 
18. At what time of the day do you think that you reach your “feeling best” peak? 
 
5:00 – 8:00 AM 5 
8:00 – 10:00 AM 4 
10:00 AM – 5:00 PM 3 
5:00 – 10:00 PM 2 
10:00 PM – 5:00 AM 1 
 
 
19. One hears about “morning” and “evening” types of people. Which ONE of these types do you 
consider yourself to be? 
 
Definitely a “morning” type 6 
Rather more a “morning” than an “evening” type 4 
Rather more an “evening” than a “morning” type  2 
Definitely an “evening” type 0 
 
                                                                       





5 mg diazepam – Stesolid 
15 mg oxazepam – Sobril 
2,5 mg nitrazepam - Nitrazepam 
1 mg lorazepam - Temesta 
0,5 mg triazolam - Halcion 
0,5 mg alprazolam - Xanor 
0,5 mg flunitrazepam – Flunitrazepam 
 
 
Tabell 2. Vanliga missbrukade bensodiazepiner – tid till tillslag, halveringstid 
och ekvivalenta doser 
 
Läkemedel      Tmax b) (timmar)   Eliminationstid c)   Dos ekvivalent med 5 mg diazepam (mg) a) 
 
Klonazepam        1–4          Lång   0,25 
Triazolam          1,7         Kort   0,25 
Alprazolam          1          Kort  0,5 
Flunitrazepam     1                 Kort                         0,5 
Lorazepam          1–2             Kort                         1,0 
Nitrazepam          1,5              Kort                         2,5 
Diazepam            1                 Lång                        5,0 
Oxazepam           2                 Kort                       15,0 
 
a) Missbrukspotentialen är främst relaterad till två variabler: affiniteten för receptorn, respektive 
snabbheten i tillslaget. Högre affinitet motsvaras (för en full agonist) av en lägre ekvipotent dos, här 
angiven i dosekvivalenter diazepam. 
b) Tid till tillslag anges här som antal timmar till maximal plasmakoncentration  
c) Ackumulationsrisken är relaterad till eliminationshalveringstiden, här grovt klassificerad som lång (> 
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